Two effective factors in cancer: Investigating the effect of ncRNAs in cancer and also the effect of nanotherapy in its treatment.

Autor: Saleh RO; Department of Medical Laboratory Techniques, Al-Maarif University College, Al-Anbar, Iraq., Yuseran H; Department of Obstetry and Ginecology, Lambung Mangkurat University Banjarmasin, Indonesia. Electronic address: hariadiyuseran@yahoo.com., Mansouri S; Department of Biomedical Technology, College of Applied Medical Sciences in Al-Kharj, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia; University of Tunis El Manar, Higher Institute of Medical Technologies of Tunis, Laboratory of Biophysics and Medical Technologies, Tunis, Tunisia., Kareem AH; College of Health and Medical Technology, Al-Ayen University, Thi-Qar, Iraq., Shakir MN; Department of Medical Laboratories Technology, AL-Nisour University College, Baghdad, Iraq., Alasheqi MQ; College of Pharmacy, National University of Science and Technology, Dhi Qar, Iraq., Akhmedovna NN; Veterinary Scientific Research Institute Tayloq, Samarkand, Uzbekistan., Dilmurodovna SI; Laboratory manager, Veterinary Scientific Research Institute Tayloq, Samarkand, Uzbekistan., Alawadi A; College of Technical Engineering, the Islamic University, Najaf, Iraq; College of Technical Engineering, the Islamic University of Al Diwaniyah, Iraq; College of Technical Engineering, the Islamic University of Babylon, Iraq., Alsalamy A; College of Technical Engineering, Imam Ja'afar Al-Sadiq University, Iraq.
Jazyk: angličtina
Zdroj: Pathology, research and practice [Pathol Res Pract] 2024 Apr; Vol. 256, pp. 155218. Date of Electronic Publication: 2024 Feb 17.
DOI: 10.1016/j.prp.2024.155218
Abstrakt: Cancer remains one of the most pressing health challenges globally, necessitating ongoing research into innovative therapeutic approaches. This article explores two critical factors influencing cancer: ncRNAs and nanotherapy. The role of ncRNAs, including microRNAs and long non-coding RNAs, in cancer pathogenesis, progression, and treatment resistance is elucidated. Additionally, the potential of nanotherapy, leveraging nanoscale materials for targeted drug delivery and enhanced therapeutic efficacy, is investigated. By comprehensively analyzing the molecular mechanisms underlying ncRNA dysregulation and the promise of nanotherapy in cancer treatment, this article aims to provide valuable insights into novel therapeutic strategies for combating cancer.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier GmbH. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: